Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 70518-3505

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 70518-3505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Picture 1 (Image 01)

Picture 1 (Image 01)
Chemical structure diagram of Lisinopril and Hydrochlorothiazide, showing molecular bonds and arrangement with associated water molecules (2H2O).*
FDA Label Image

Picture 2 (Image 02)

Picture 2 (Image 02)
Chemical structure of Lisinopril and Hydrochlorothiazide, the active ingredients in the Lisinopril and Hydrochlorothiazide tablets from REMEDYREPACK INC. The image shows the molecular arrangement of these compounds.*
FDA Label Image

Mm1 (Lisinopril Hctz 20mg 12.5mg 70518 3505 00)

Mm1 (Lisinopril   Hctz 20mg   12.5mg 70518 3505 00)
Lisinopril / HCTZ Tablet, 20 mg / 12.5 mg, oral tablet, quantity 90 tablets. Label indicates NDC 70518-3505-00, repackaged by RemedyRepack Inc., Indiana, PA 15701. The label includes storage instructions to protect from excessive light and humidity, and recommended temperature storage between 20-25°C with allowed excursions. The tablet is described as round yellow with imprint H151.*
FDA Label Image

Mm2 (Lisinopril Hctz 20mg 12.5mg 70518 3505 01)

Mm2 (Lisinopril   Hctz 20mg   12.5mg 70518 3505 01)
Lisinopril and Hydrochlorothiazide Tablets 20 mg / 12.5 mg in a bottle label for 30 tablets. The label includes the NDC number 70518-3505-01 and states the product is round yellow tablets marked H151. It is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and reminders to keep out of reach of children are also shown.*
FDA Label Image

Mm3 (Lisinopril Hctz 20mg 12.5mg 70518 3505 02)

Mm3 (Lisinopril   Hctz 20mg   12.5mg 70518 3505 02)
Label for Lisinopril and Hydrochlorothiazide Tablets 20 mg / 12.5 mg showing a 30-tablet quantity. The label includes storage instructions, repackager information (RemedyRepack Inc., Indiana, PA), and a note that it is prescription only. The tablets are described as round and yellow.*
FDA Label Image

Mm4 (Lisinopril Hctz 20mg 12.5mg 70518 3505 03)

Mm4 (Lisinopril   Hctz 20mg   12.5mg 70518 3505 03)
Lisinopril and Hydrochlorothiazide Tablets 20 mg / 12.5 mg label showing quantity of 90 tablets. The label includes storage instructions to protect from light and humidity and to store between 20-25°C with permitted excursions. It is repackaged by RemedyRepack Inc., Indiana, PA. The label indicates the tablets are round yellow, marked H151, and includes NDC 70518-3505-03 with RX only status.*
FDA Label Image

Mm5 (Lisinopril Hctz 20mg 12.5mg 70518 3505 04)

Mm5 (Lisinopril   Hctz 20mg   12.5mg 70518 3505 04)
Label for Lisinopril / HCTZ Tablet 20 mg / 12.5 mg, containing 100 tablets. The label indicates the NDC number 70518-3505-04 and describes the tablets as round, yellow, marked H151. It includes storage instructions, a note to keep medication out of children's reach, and contact information for RemedyRepack Inc., the repackager located in Indiana, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.